These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7201207)

  • 41. [Cis-DDP (cis-diaminodichloroplatinum II) in the treatment of solid tumors. Apropos of 28 cases].
    Adenis L; Cappelaere P; Vallet D; Bonneterre J
    Lille Med; 1979; 24(6):431-5. PubMed ID: 502731
    [No Abstract]   [Full Text] [Related]  

  • 42. Cis-platinum: a brief review of its use, and nursing guidelines.
    Ellington OB
    Cancer Nurs; 1978 Oct; 1(5):403-6. PubMed ID: 359123
    [No Abstract]   [Full Text] [Related]  

  • 43. Cis-platinum in cancer chemotherapy: a significant advance.
    Helmers R; Clamon G
    J Iowa Med Soc; 1982 Nov; 72(11):464-5, 468. PubMed ID: 6890970
    [No Abstract]   [Full Text] [Related]  

  • 44. Platinum coordination complexes in cancer chemotherapy.
    Rosenberg B
    Naturwissenschaften; 1973 Sep; 60(9):399-406. PubMed ID: 4203933
    [No Abstract]   [Full Text] [Related]  

  • 45. [Organic compounds containing platinum and antineoplastic chemotherapy].
    Israel L; Aguilera J
    Sem Hop Ther; 1977 Nov; 53(9):470-2. PubMed ID: 601566
    [No Abstract]   [Full Text] [Related]  

  • 46. Cisplatin for adrenal cortical carcinoma.
    Chun HG; Yagoda A; Kemeny N; Watson RC
    Cancer Treat Rep; 1983 May; 67(5):513-4. PubMed ID: 6682704
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical pharmacology of cis-diamminedichloroplatinum and its value in the chemotherapy of neoplasms].
    Robak T; Płuzańska A
    Pol Arch Med Wewn; 1983 Jan; 69(1):59-67. PubMed ID: 6351029
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical implications of cisplatin pharmacology.
    Muggia FM; Rozencweig M; Penta J
    Recent Results Cancer Res; 1980; 74():132-8. PubMed ID: 7192424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trial.
    Hayat M; Brulé G; Cappelaere P; Cattan A; Chauvergne J; Clavel B; Guerrin J; Misset JL; Pommatau E; Ribaud P; Muggia FM; Rozencweig M; Mathé G
    Recent Results Cancer Res; 1980; 74():139-45. PubMed ID: 7192425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Adverse reactions to cisplatin in patients with malignant tumors].
    Lalowicz I
    Pol Tyg Lek; 1989 Jun 19-26; 44(25-26):621-3. PubMed ID: 2700229
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cis-dichlorodiammineplatinum, a representative of a new group of cytostatic drugs].
    Janas J
    Nowotwory; 1981; 31(3-4):251-6. PubMed ID: 7045812
    [No Abstract]   [Full Text] [Related]  

  • 52. [Problem on the chemotherapy of malignant tumors abroad].
    Garin AM
    Vopr Onkol; 1978; 24(5):51-4. PubMed ID: 664536
    [No Abstract]   [Full Text] [Related]  

  • 53. Utilization of a standard form for the administration of cis-platinum in a community hospital.
    Valenzano L
    NITA; 1984; 7(6):515-6. PubMed ID: 6568463
    [No Abstract]   [Full Text] [Related]  

  • 54. A pilot study using 99mTc to measure lead and platinum in the human kidney.
    Todd AC; Chettle DR; Scott MC; Somervaille LJ; Braithwaite RA; Beaney RP; Buxton EJ
    Nucl Med Biol; 1993 Jul; 20(5):589-95. PubMed ID: 8358344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Summary of investigations on platinum compounds and radiation interactions.
    Muggia FM; Glatstein E
    Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1407-9. PubMed ID: 393674
    [No Abstract]   [Full Text] [Related]  

  • 56. Cis-platinum for cancer.
    Hill NO
    N Engl J Med; 1979 Jul; 301(1):47. PubMed ID: 449909
    [No Abstract]   [Full Text] [Related]  

  • 57. [Platidiam--advantages and hazards of a new cytostatic].
    Vorlícek J; Mechl Z
    Cas Lek Cesk; 1982 Jul; 121(28):880-1. PubMed ID: 6889462
    [No Abstract]   [Full Text] [Related]  

  • 58. [Catamnestic-statistical results of Proresid treatment of malignant tumors].
    Trüb CL; Pohlschmidt L
    Ther Ggw; 1978 Mar; 117(3):358-76. PubMed ID: 635819
    [No Abstract]   [Full Text] [Related]  

  • 59. Cisplatin: contemporary treatment approaches.
    Semin Oncol; 1989 Aug; 16(4 Suppl 6):1-128. PubMed ID: 2762826
    [No Abstract]   [Full Text] [Related]  

  • 60. [Nitrosomethylurea in the clinical chemotherapy of malignant tumors].
    Dement'eva NP
    Vopr Onkol; 1988; 34(1):8-17. PubMed ID: 3277333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.